BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nabi B, Rehman S, Aggarwal S, Baboota S, Ali J. Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention. Drug Deliv Transl Res 2020;10:1111-21. [PMID: 32418158 DOI: 10.1007/s13346-020-00786-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Verma N, Arora V, Awasthi R, Chan Y, Jha NK, Thapa K, Jawaid T, Kamal M, Gupta G, Liu G, Paudel KR, Hansbro PM, George Oliver BG, Singh SK, Chellappan DK, Dureja H, Dua K. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis. Journal of Drug Delivery Science and Technology 2022;75:103690. [DOI: 10.1016/j.jddst.2022.103690] [Reference Citation Analysis]
2 Trousil J, Dal NK, Fenaroli F, Schlachet I, Kubíčková P, Janoušková O, Pavlova E, Škorič M, Trejbalová K, Pavliš O, Sosnik A. Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen. Small 2022;:e2201853. [PMID: 35691939 DOI: 10.1002/smll.202201853] [Reference Citation Analysis]
3 Huck BC, Thiyagarajan D, Bali A, Boese A, Besecke KFW, Hozsa C, Gieseler RK, Furch M, Carvalho-Wodarz C, Waldow F, Schwudke D, Metelkina O, Titz A, Huwer H, Schwarzkopf K, Hoppstädter J, Kiemer AK, Koch M, Loretz B, Lehr CM. Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery. Adv Healthc Mater 2022;11:e2102117. [PMID: 35112802 DOI: 10.1002/adhm.202102117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Khoza LJ, Kumar P, Dube A, Demana PH, Choonara YE. Insights into Innovative Therapeutics for Drug-Resistant Tuberculosis: Host-Directed Therapy and Autophagy Inducing Modified Nanoparticles. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121893] [Reference Citation Analysis]
5 Chaudhary KR, Puri V, Singh A, Singh C. A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2021.103069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Javed MN, Akhter MH, Taleuzzaman M, Faiyazudin M, Alam MS. Cationic nanoparticles for treatment of neurological diseases. Fundamentals of Bionanomaterials 2022. [DOI: 10.1016/b978-0-12-824147-9.00010-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Santos F, Duarte ARC. Combination drug delivery approaches for tuberculosis. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 2022. [DOI: 10.1016/b978-0-323-85873-1.00006-x] [Reference Citation Analysis]
8 Limocon JRA, Madalag LMC, Reliquias PJB, Tionko JVS, Fermin JL, Kee SL, Tan MJT, Jonco MJJ, Pomperada MJF. Small but Terrible: Utilizing Chitosan-Based Nanoparticles as Drug Carriers to Treat Tuberculosis in the Philippines. Front Pharmacol 2021;12:752107. [PMID: 34690783 DOI: 10.3389/fphar.2021.752107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fernández-Paz C, Fernández-Paz E, Salcedo-Abraira P, Rojas S, Barrios-Esteban S, Csaba N, Horcajada P, Remuñán-López C. Microencapsulated Isoniazid-Loaded Metal-Organic Frameworks for Pulmonary Administration of Antituberculosis Drugs. Molecules 2021;26:6408. [PMID: 34770817 DOI: 10.3390/molecules26216408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Doroudian M, O' Neill A, Mac Loughlin R, Prina-Mello A, Volkov Y, Donnelly SC. Nanotechnology in pulmonary medicine. Curr Opin Pharmacol 2021;56:85-92. [PMID: 33341460 DOI: 10.1016/j.coph.2020.11.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]